PRVA Earnings & Financial Statements
Privia Health Group, Inc.
$21.67
+$0.02(+0.09%)
55
Overall
40
Value
70
Tech
55
Quality
Market Cap
$2.77B
Volume
1.17M
52W Range
$18.92 - $28.82
Target Price
$31.47
PRVA earnings and financial statements: Privia Health Group, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PRVA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.12B | $1.74B | $1.66B | $1.36B | $966.22M |
| Cost of revenue | $1.91B | $1.56B | $1.50B | $1.22B | - |
| Operating income | $34.23M | $16.98M | $20.65M | -$19.12M | -$217.44M |
| EBITDA | $53.88M | $35.17M | $42.13M | -$13.81M | -$214.83M |
| Net income | $22.92M | $14.38M | $23.08M | -$8.59M | -$188.23M |
| EPS (diluted) | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.37B | $1.14B | $999.90M | $792.81M | $686.37M |
| Total liabilities | $578.43M | $452.34M | $392.51M | $273.76M | $236.19M |
| Shareholders’ equity | $737.22M | $635.18M | $561.44M | $499.09M | $426.87M |
| Cash and equivalents | $479.69M | $491.15M | $389.51M | $347.99M | $320.58M |
| Long-term debt | $7.33M | $3.04M | $5.25M | $8.49M | $42.73M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $163.40M | $109.28M | $80.78M | $47.20M | $55.06M |
| Capital expenditure | - | - | -$113.0K | -$104.0K | -$547.0K |
| Free cash flow | $163.40M | $109.28M | $80.78M | $47.20M | $54.51M |
| Dividends paid | $1.34M | - | - | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRVA | $21.67 | +0.1% | 1.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Privia Health Group, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW